Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program endorsed by ISBER. This testing program is an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods. The Radboud Biobank participated in the program for viable PBMC isolation and the program for cell free DNA Extraction from whole blood. Stabilized whole blood received from IBBL was processed by the Radboud Laboratory for Diagnostics by our standard procedure followed by the cfDNA extraction performed by the Genetics department. The PBMCs were isolated from donor blood by the Laboratory of Medical Immunology with the AutoMACS.
DNA and PBMCs where sent back to IBBL for the analysis. Recently we received the reports of the Proficiency tests which resulted in a quality certificate for both methods. The participants’ mean (n=11 cfDNA and n=53 PBMC) is considered as the assigned value and basic statistics were performed.
If you are interested in the methods or report in more detail, please contact the Radboud Biobank.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
National Biobanks & Collections day
19 October 2023The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.
read moreTETRO-trial
30 March 2023The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.
read moreArchipelago
30 March 2023Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.
read moreTheme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard
30 March 2023In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.
read moreHealth-RI receives definitive follow-up funding from the National Growth Fund
30 March 2023The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.
read more